This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roylance, R. Articles by Sheer, D. Search for Related Content PubMed PubMed Citation Articles by Roylance, R. Articles by Sheer, D.

Comparative Genomic Hybridization of Breast Tumors Stratified by Histological Grade Reveals New Insights into the Biological Progression of Breast Cancer

Human Cytogenetics Laboratory, Imperial Cancer Research Fund, London WC2A 3PX [R. R., P. G., D. S.], and Hedley Atkins/ICRF Breast Pathology Laboratory, Guy’s Hospital, London SE1 9RT [W. H., R. L., D. B., A. H.], United Kingdom

How does breast cancer progress? There is evidence both to support (S. W. Duffy et al., Br. J. Cancer, 64: 1133–1138, 1991; R. Rajakariar et al., Br. J. Cancer, 71: 150–154, 1995) and refute (M. Hakama et al., Lancet, 345: 221–224, 1995; R. R. Millis et al., Eur. J. Cancer, 34: 548–553, 1998) the hypothesis of dedifferentiation; the theory that as breast cancers grow they evolve from well differentiated (grade I) to poorly differentiated (grade III) tumors. We provide evidence to support the view that the majority of grade I tumors do not progress to grade III tumors. Comparative genomic hybridization was used to screen entire genomes of a large sample (40 grade I and 50 grade III) of invasive ductal breast carcinomas, stratified by grade. We found distinct genetic differences between grade I and grade III tumors. Significantly, we found that 65% of grade I tumors lost the long arm of chromosome 16 compared with only 16% of grade III tumors. This pattern of loss leads us to conclude that the majority of grade I tumors do not progress to grade III tumors. These findings have important implications because they suggest that different breast tumor grades may have distinct molecular origins, pathogenesis, and behavior and, therefore, potentially present distinct molecular targets for research and treatment.

This article has been cited by other articles:

				E Korsching, S S Jeffrey, W Meinerz, T Decker, W Boecker, and H Buerger Basal carcinoma of the breast revisited: an old entity with new interpretations J. Clin. Pathol., May 1, 2008; 61(5): 553 - 560. [Abstract] [Full Text] [PDF]

				L. Melchor, E. Honrado, J. Huang, S. Alvarez, T. L. Naylor, M. J. Garcia, A. Osorio, D. Blesa, M. R. Stratton, B. L. Weber, et al. Estrogen Receptor Status Could Modulate the Genomic Pattern in Familial and Sporadic Breast Cancer Clin. Cancer Res., December 15, 2007; 13(24): 7305 - 7313. [Abstract] [Full Text] [PDF]

				L Da Silva, C Clarke, and S R Lakhani Demystifying basal-like breast carcinomas J. Clin. Pathol., December 1, 2007; 60(12): 1328 - 1332. [Abstract] [Full Text] [PDF]

				M. W. Jenner, P. E. Leone, B. A. Walker, F. M. Ross, D. C. Johnson, D. Gonzalez, L. Chiecchio, E. Dachs Cabanas, G. Paolo Dagrada, M. Nightingale, et al. Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma Blood, November 1, 2007; 110(9): 3291 - 3300. [Abstract] [Full Text] [PDF]

				L. Nakopoulou, E. G Panayotopoulou, I. Giannopoulou, I. Tsirmpa, S. Katsarou, E. Mylona, P. Alexandrou, and A. Keramopoulos Extra copies of chromosomes 16 and X in invasive breast carcinomas are related to aggressive phenotype and poor prognosis J. Clin. Pathol., July 1, 2007; 60(7): 808 - 815. [Abstract] [Full Text] [PDF]

				A. V. Ivshina, J. George, O. Senko, B. Mow, T. C. Putti, J. Smeds, T. Lindahl, Y. Pawitan, P. Hall, H. Nordgren, et al. Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer Cancer Res., November 1, 2006; 66(21): 10292 - 10301. [Abstract] [Full Text] [PDF]

				M. Dolled-Filhart, L. Ryden, M. Cregger, K. Jirstrom, M. Harigopal, R. L. Camp, and D. L. Rimm Classification of breast cancer using genetic algorithms and tissue microarrays. Clin. Cancer Res., November 1, 2006; 12(21): 6459 - 6468. [Abstract] [Full Text] [PDF]

				L. Melchor, S. Alvarez, E. Honrado, J. Palacios, A. Barroso, O. Diez, A. Osorio, and J. Benitez The Accumulation of Specific Amplifications Characterizes Two Different Genomic Pathways of Evolution of Familial Breast Tumors Clin. Cancer Res., December 15, 2005; 11(24): 8577 - 8584. [Abstract] [Full Text] [PDF]

				J Packeisen, K Nakachi, W Boecker, B Brandt, and H Buerger Cytogenetic differences in breast cancer samples between German and Japanese patients J. Clin. Pathol., October 1, 2005; 58(10): 1101 - 1103. [Abstract] [Full Text] [PDF]

				J. B. Arnes, J.-S. Brunet, I. Stefansson, L. R. Begin, N. Wong, P. O. Chappuis, L. A. Akslen, and W. D. Foulkes Placental Cadherin and the Basal Epithelial Phenotype of BRCA1-Related Breast Cancer Clin. Cancer Res., June 1, 2005; 11(11): 4003 - 4011. [Abstract] [Full Text] [PDF]

				L. W. M. Loo, D. I. Grove, E. M. Williams, C. L. Neal, L. A. Cousens, E. L. Schubert, I. N. Holcomb, H. F. Massa, J. Glogovac, C. I. Li, et al. Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes Cancer Res., December 1, 2004; 64(23): 8541 - 8549. [Abstract] [Full Text] [PDF]

				C. Jones, E. Ford, C. Gillett, K. Ryder, S. Merrett, J. S. Reis-Filho, L. G. Fulford, A. Hanby, and S. R. Lakhani Molecular Cytogenetic Identification of Subgroups of Grade III Invasive Ductal Breast Carcinomas with Different Clinical Outcomes Clin. Cancer Res., September 15, 2004; 10(18): 5988 - 5997. [Abstract] [Full Text] [PDF]

				M Lacroix, R-A Toillon, and G Leclercq Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics Endocr. Relat. Cancer, September 1, 2004; 11(3): 497 - 522. [Abstract] [Full Text] [PDF]

				E. S. Hwang, S. DeVries, K. L. Chew, D. H. Moore II, K. Kerlikowske, A. Thor, B.-M. Ljung, and F. M. Waldman Patterns of Chromosomal Alterations in Breast Ductal Carcinoma In situ Clin. Cancer Res., August 1, 2004; 10(15): 5160 - 5167. [Abstract] [Full Text] [PDF]

				Z. C. Wang, M. Lin, L.-J. Wei, C. Li, A. Miron, G. Lodeiro, L. Harris, S. Ramaswamy, D. M. Tanenbaum, M. Meyerson, et al. Loss of Heterozygosity and Its Correlation with Expression Profiles in Subclasses of Invasive Breast Cancers Cancer Res., January 1, 2004; 64(1): 64 - 71. [Abstract] [Full Text] [PDF]

				T J Anderson, C Davis, F E Alexander, and H M Dobson Measures of benefit for breast screening from the pathology database for Scotland, 1991-2001 J. Clin. Pathol., September 1, 2003; 56(9): 654 - 659. [Abstract] [Full Text] [PDF]

				O. M. Sieber, K. Heinimann, P. Gorman, H. Lamlum, M. Crabtree, C. A. Simpson, D. Davies, K. Neale, S. V. Hodgson, R. R. Roylance, et al. Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC PNAS, December 24, 2002; 99(26): 16910 - 16915. [Abstract] [Full Text] [PDF]

				L. F. A. Wessels, T. van Welsem, A. A. M. Hart, L. J. van't Veer, M. J. T. Reinders, and P. M. Nederlof Molecular Classification of Breast Carcinomas by Comparative Genomic Hybridization: a Specific Somatic Genetic Profile for BRCA1 Tumors Cancer Res., December 1, 2002; 62(23): 7110 - 7117. [Abstract] [Full Text] [PDF]

				J. Climent, J. A. Martinez-Climent, D. Blesa, M. J. Garcia-Barchino, R. Saez, D. Sanchez-Izquierdo, P. Azagra, A. Lluch, and J. Garcia-Conde Genomic Loss of 18p Predicts an Adverse Clinical Outcome in Patients with High-Risk Breast Cancer Clin. Cancer Res., December 1, 2002; 8(12): 3863 - 3869. [Abstract] [Full Text] [PDF]

				A. Dellas, J. Torhorst, E. Schultheiss, M. J. Mihatsch, and H. Moch DNA Sequence Losses on Chromosomes 11p and 18q Are Associated with Clinical Outcome in Lymph Node-negative Ductal Breast Cancer Clin. Cancer Res., May 1, 2002; 8(5): 1210 - 1216. [Abstract] [Full Text] [PDF]

				G Cserni Tumour histological grade may progress between primary and recurrent invasive mammary carcinoma J. Clin. Pathol., April 1, 2002; 55(4): 293 - 297. [Abstract] [Full Text] [PDF]

				A Martinez, R A Walker, J A Shaw, S J Dearing, E R Maher, and F Latif Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features Mol. Pathol., October 1, 2001; 54(5): 300 - 306. [Abstract] [Full Text] [PDF]

				O. Monni, M. Bärlund, S. Mousses, J. Kononen, G. Sauter, M. Heiskanen, P. Paavola, K. Avela, Y. Chen, M. L. Bittner, et al. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer PNAS, April 25, 2001; (2001) 91582298. [Abstract] [Full Text]

				A.-M. Cleton-Jansen, D. F. Callen, R. Seshadri, S. Goldup, B. McCallum, J. Crawford, J. A. Powell, C. Settasatian, H. van Beerendonk, E. W. Moerland, et al. Loss of Heterozygosity Mapping at Chromosome Arm 16q in 712 Breast Tumors Reveals Factors that Influence Delineation of Candidate Regions Cancer Res., February 1, 2001; 61(3): 1171 - 1177. [Abstract] [Full Text]

				I P M Tomlinson, R Roylance, and R S Houlston Two hits revisited again J. Med. Genet., February 1, 2001; 38(2): 81 - 85. [Abstract] [Full Text]

				V. L. Seewaldt, K. Mrózek, E. C. Dietze, M. Parker, and L. E. Caldwell Human Papillomavirus Type 16 E6 Inactivation of p53 in Normal Human Mammary Epithelial Cells Promotes Tamoxifen-mediated Apoptosis Cancer Res., January 1, 2001; 61(2): 616 - 624. [Abstract] [Full Text]

				E. Dublin, A. Hanby, N. K. Patel, R. Liebman, and D. Barnes Immunohistochemical Expression of uPA, uPAR, and PAI-1 in Breast Carcinoma : Fibroblastic Expression Has Strong Associations with Tumor Pathology Am. J. Pathol., October 1, 2000; 157(4): 1219 - 1227. [Abstract] [Full Text] [PDF]

				F. Forozan, E. H. Mahlamäki, O. Monni, Y. Chen, R. Veldman, Y. Jiang, G. C. Gooden, S. P. Ethier, A. Kallioniemi, and O.-P. Kallioniemi Comparative Genomic Hybridization Analysis of 38 Breast Cancer Cell Lines: A Basis for Interpreting Complementary DNA Microarray Data Cancer Res., August 1, 2000; 60(16): 4519 - 4525. [Abstract] [Full Text]

				C.-Y. Shen, J.-C. Yu, Y.-L. Lo, C.-H. Kuo, C.-T. Yue, Y.-S. Jou, C.-S. Huang, J.-C. Lung, and C.-W. Wu Genome-wide Search for Loss of Heterozygosity Using Laser Capture Microdissected Tissue of Breast Carcinoma: An Implication for Mutator Phenotype and Breast Cancer Pathogenesis Cancer Res., July 1, 2000; 60(14): 3884 - 3892. [Abstract] [Full Text]

				A. J. W. Paige, K. J. Taylor, A. Stewart, J. G. Sgouros, H. Gabra, G. C. Sellar, J. F. Smyth, D. J. Porteous, and J. E. V. Watson A 700-kb Physical Map of a Region of 16q23.2 Homozygously Deleted in Multiple Cancers and Spanning the Common Fragile Site FRA16D Cancer Res., March 1, 2000; 60(6): 1690 - 1697. [Abstract] [Full Text]

				M. S. Rogers and E. E. Strehler The Tumor-sensitive Calmodulin-like Protein Is a Specific Light Chain of Human Unconventional Myosin X J. Biol. Chem., April 6, 2001; 276(15): 12182 - 12189. [Abstract] [Full Text] [PDF]

				O. Monni, M. Barlund, S. Mousses, J. Kononen, G. Sauter, M. Heiskanen, P. Paavola, K. Avela, Y. Chen, M. L. Bittner, et al. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer PNAS, May 8, 2001; 98(10): 5711 - 5716. [Abstract] [Full Text] [PDF]